Hoth Therapeutics Company Top Insiders
HOTH Stock | USD 1.25 0.09 6.72% |
Hoth Therapeutics employs about 2 people. The company is managed by 5 executives with a total tenure of roughly 5 years, averaging almost 1.0 years of service per executive, having 0.4 employees per reported executive. Assessment of Hoth Therapeutics' management performance can provide insight into the firm performance.
Hoth Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.5715) % which means that it has lost $0.5715 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9826) %, meaning that it created substantial loss on money invested by shareholders. Hoth Therapeutics' management efficiency ratios could be used to measure how well Hoth Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.11. The current Return On Capital Employed is estimated to decrease to -1.25. As of now, Hoth Therapeutics' Net Tangible Assets are increasing as compared to previous years. The Hoth Therapeutics' current Other Current Assets is estimated to increase to about 587.1 K, while Total Assets are projected to decrease to under 6.2 M.The Hoth Therapeutics' current Common Stock Shares Outstanding is estimated to increase to about 6.7 M, while Net Loss is forecasted to increase to (12.2 M).
Hoth Therapeutics Workforce Comparison
Hoth Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 86.0. Hoth Therapeutics holds roughly 2.0 in number of employees claiming about 2.33% of equities under Health Care industry.
Hoth Therapeutics Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hoth Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hoth Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Hoth Therapeutics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Camarra Christopher Michael over two months ago Insider Trading | ||
Sarnoff David over three months ago Acquisition by Sarnoff David of 40000 shares of Hoth Therapeutics subject to Rule 16b-3 | ||
Ahern James P. over three months ago Disposition of tradable shares by Ahern James P. of Hoth Therapeutics subject to Rule 16b-3 | ||
David Briones over three months ago Insider Trading | ||
Springer Graig over three months ago Acquisition by Springer Graig of 33000 shares of Hoth Therapeutics at 2.11 subject to Rule 16b-3 | ||
Springer Graig over six months ago Acquisition by Springer Graig of 70000 shares of Hoth Therapeutics at 1.55 subject to Rule 16b-3 | ||
Hayes Anthony over six months ago Disposition of tradable shares by Hayes Anthony of Hoth Therapeutics subject to Rule 16b-3 | ||
Poor Kevin Jess over six months ago Acquisition by Poor Kevin Jess of 750000 shares of Hoth Therapeutics subject to Rule 16b-3 |
Hoth Therapeutics Notable Stakeholders
A Hoth Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Hoth Therapeutics often face trade-offs trying to please all of them. Hoth Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Hoth Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Robb Knie | President, Founder | Profile | |
Jane Springer | VP Operations | Profile | |
Hayley Springer | Executive Operations | Profile | |
Stefanie Johns | Chief Officer | Profile | |
David Briones | Chief Officer | Profile |
About Hoth Therapeutics Management Performance
The success or failure of an entity such as Hoth Therapeutics often depends on how effective the management is. Hoth Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Hoth management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Hoth management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.06) | (1.11) | |
Return On Capital Employed | (1.19) | (1.25) | |
Return On Assets | (1.06) | (1.11) | |
Return On Equity | (1.19) | (1.25) |
Hoth Therapeutics Workforce Analysis
Traditionally, organizations such as Hoth Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Hoth Therapeutics within its industry.Hoth Therapeutics Manpower Efficiency
Return on Hoth Therapeutics Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 4.1M | |
Net Loss Per Executive | 1.6M | |
Working Capital Per Employee | 3.4M | |
Working Capital Per Executive | 1.4M |
Complementary Tools for Hoth Stock analysis
When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |